EMERGENT BIOSOLUTIONS INC. Other Comprehensive Income (Loss), Net of Tax
EMERGENT BIOSOLUTIONS INC. (EBS) reported Other Comprehensive Income (Loss), Net of Tax of -$4.10 million for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-11-07.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2019-11-07
- EMERGENT BIOSOLUTIONS INC. other comprehensive income (loss), net of tax for the quarter ending 2019-09-30 was -$4.10M.
- EMERGENT BIOSOLUTIONS INC. other comprehensive income (loss), net of tax for the quarter ending 2019-06-30 was -$500.00K.
- EMERGENT BIOSOLUTIONS INC. other comprehensive income (loss), net of tax for the quarter ending 2019-03-31 was $1.00M, a 150.00% increase year-over-year.
- EMERGENT BIOSOLUTIONS INC. other comprehensive income (loss), net of tax for the quarter ending 2018-12-31 was -$800.00K.
- EMERGENT BIOSOLUTIONS INC. other comprehensive income (loss), net of tax for fiscal 2018 was -$1.80M, a 400.00% decline from fiscal 2017.
- EMERGENT BIOSOLUTIONS INC. other comprehensive income (loss), net of tax for fiscal 2017 was $600.00K.
- EMERGENT BIOSOLUTIONS INC. other comprehensive income (loss), net of tax for fiscal 2016 was -$1.60M.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|
| 2019-09-30 | -$4.10M 10-Q · filed 2019-11-07 | -$4.60M derived: sum of 2 quarters · filed 2019-11-07 | -$3.60M 10-Q · filed 2019-11-07 | -$4.40M derived: sum of 4 quarters · filed 2019-11-07 |
| 2019-06-30 | -$500.00K 10-Q · filed 2019-08-02 | $500.00K 10-Q · filed 2019-08-02 | -$300.00K derived: sum of 3 quarters · filed 2019-08-02 | -$500.00K derived: sum of 4 quarters · filed 2019-11-07 |
| 2019-03-31 | $1.00M 10-Q · filed 2019-05-08 | $200.00K derived: sum of 2 quarters · filed 2019-05-08 | $0.00 derived: sum of 3 quarters · filed 2019-11-07 | -$1.20M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-12-31 | -$800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | -$1.00M derived: sum of 2 quarters · filed 2019-11-07 | -$2.20M derived: sum of 3 quarters · filed 2019-11-07 | -$1.80M 10-K · filed 2019-02-22 |
| 2018-09-30 | -$200.00K 10-Q · filed 2019-11-07 | -$1.40M derived: sum of 2 quarters · filed 2019-11-07 | -$1.00M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | -$1.20M 10-Q · filed 2019-08-02 | -$700.00K 10-Q · filed 2019-08-02 | ||
| 2018-03-31 | $400.00K 10-Q · filed 2019-05-08 | |||
| 2017-12-31 | $600.00K 10-K · filed 2019-02-22 | |||
| 2016-12-31 | -$1.60M 10-K · filed 2019-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |